Normalized synergy increased with greater recurrence and decreased with greater feedback. by Samantha P. Sherrill (11114128)

“…The background heatmap, wherein brighter colors reflect larger normalized synergy values, replots the central tendency of the values shown in <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1009196#pcbi.1009196.g003" target="_blank">Fig 3</a>. …”

Patients with high baseline gut richness and diversity have significantly greater decreases in diversity over time. by Molly B. El Alam (10231830)

Table_2_Maternal oral probiotic use is associated with decreased breastmilk inflammatory markers, infant fecal microbiome variation, and altered recognition memory responses in infants—a pilot observational study.XLSX by Sara Gonia (14132166)

“…Specifically, infants who were exposed to postnatal maternal probiotics (between the 1- and 6-month study visits) via breastfeeding/breastmilk, had larger differential responses between familiar and novel visual stimuli with respect to the late slow wave component of the EEG, which may indicate greater memory updating potential. …”

Table_1_Maternal oral probiotic use is associated with decreased breastmilk inflammatory markers, infant fecal microbiome variation, and altered recognition memory responses in infants—a pilot observational study.XLSX by Sara Gonia (14132166)

“…Specifically, infants who were exposed to postnatal maternal probiotics (between the 1- and 6-month study visits) via breastfeeding/breastmilk, had larger differential responses between familiar and novel visual stimuli with respect to the late slow wave component of the EEG, which may indicate greater memory updating potential. …”

Average susceptibility decreases over exposure events in a heterogeneous population. by Beth M. Tuschhoff (19251419)

Changes in baseline T-cell activation markers through week 12 and week 24 according to the linear regression model. a. by Tosi M. Mwakyandile (16408705)

Data_Sheet_1_Immune and Neuroendocrine Trait and State Markers in Psychotic Illness: Decreased Kynurenines Marking Psychotic Exacerbations.docx by Livia De Picker (8319105)

“…Normalization of KA and 3-HK levels between admission and follow-up corresponded to a larger improvement of negative symptoms (r = 0.5, p < 0.030) A reverse association was found between relative improvement of SDST scores and decreasing KA levels (r = 0.5, p < 0.010).…”

Hypoalbuminemia is a frequent marker of increased mortality in cardiogenic shock by Toni Jäntti (6707633)

Changes in baseline T-cell exhaustion, monocyte activation and platelet activation markers through week 12 and week 24 according to the linear regression model. a. by Tosi M. Mwakyandile (16408705)

The sheets in this spreadsheet displays all of our results, including a summary table of our main findings, all sensitivity analyses (different MR methods, sensitivity analyses rel... by Alish B. Palmos (5857379)

Loss of ECRG4 expression decreases neutrophil mobilization from bone marrow reserves. by Katie D. Pool (20141584)

Cell proliferation was decreased more by combination treatment of SLCP and BBR than individual treatments. by Panchanan Maiti (1459852)

“…Note that combination treatment (right image) caused a greater decrease in the immunofluorescent signal than did the single treatment (p<0.01). …”

Receiver entropy decreased with greater recurrence and increased with greater feedback. by Samantha P. Sherrill (11114128)

Example of categorisation of scoring periods as either increasing or decreasing tail injury. by Richard B. D’Eath (4666777)

A noxious temperature decrease without a prior increase produces a subtly larger decrease in pain intensity. by Benedict J. Alter (9745466)

Validation of genetic markers for risk of OA or knee OA for decrease in minJSW. by Mieke L. M. Bentvelzen (21594442)

Nimodipine does not decrease markers of neuritic dystrophy in 5XFAD transgenic mice. by Katherine R. Sadleir (12035242)

“…Similarly, BACE1, LAMP1 and LC3B-II/ LC3B-I were also increased in nimodipine-treated 5XFAD compared to nimodipine treated non-transgenic mice, indicating that nimodipine did not decrease the accumulation of these dystrophic neurite marker proteins. …”

Activation markers and cytokine production. by Isaiah R. Turnbull (9351911)

Marker genes for the lymphoid clusters. by Emilie Pollenus (10147748)

Marker genes for the myeloid clusters. by Emilie Pollenus (10147748)